Krystal Biotechs’ KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis
Placement to Institutional and Sophisticated Investors, Appointment of Joint Broker,Issue of Equity & TVR
